Timothy Sullivan - Feb 12, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Financial Officer
Signature: /s/s David Watson, attorney-in-fact for Timothy Sullivan
Stock symbol: APLS
Transactions as of: Feb 12, 2024
Transactions value $: -$96,974
Form type: 4
Date filed: 2/13/2024, 04:59 PM
Previous filing: Jan 31, 2024
Next filing: Mar 5, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Sale	-$97K	-1.43K	-1.51%	$67.77	93.3K	Feb 12, 2024	Direct	F1
holding	APLS	Common Stock						56.2K	Feb 12, 2024	The Timothy E Sullivan Irrevocable Trust of 2023	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents shares sold to cover tax withholding on the Restricted Stock Units released on 02/09/2024.
F2	The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.